CELL & GENE THERAPY INSIGHTS

Gene delivery/gene editing platform evolution

Louise Rodino-Klapac
Guest Editor:
Louise Rodino-Klapac, EVP, Head of R&D, Chief Scientific Officer at Sarepta Therapeutics
May 2022